In a cross-over study [16] which forms the pilot data for this trial, patients in the MedDiet arm had significant improvements in insulin sensitivity as determined by a 3-hour hyperinsulinaemic-euglycaemic clamp and a significant reduction (39 %) in hepatic steatosis. Here, INS is linked to fatty liver disease.